Lara Goldstein - Spark Newswire

1 minute read

Psychedelics Company Nabs Health Canada Construction Permit, Find Out How They Got It

Today, 4:03 PM

Canadian life sciences company Nirvana Life Sciences Inc. (CSE: NIRV), focused on research & development of non-addictive pain management and relapse prevention products for pain and addictions, has been granted approval to build its R&D facility in Vancouver by Canada’s governmental department of Health.

CSE:NIRV

2 minute read

HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details

By Lara Goldstein

Today, 4:03 PM

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its therapeutic retreats in Jamaica and Optimi Health Corp.

HAVLF

2 minute read

Meet Alvaro Torres, CEO Of Lat Am & UK’s Top Medical Marijuana Brand At Benzinga’s Cannabis Capital Conference In September

By Lara Goldstein

Today, 4:03 PM

After a prosperous Miami event this past April, the Benzinga Cannabis Capital Conference will take place in Chicago on September 13-14. As always, the meeting will host leading executives and investors who will talk about the industry’s present and future.

KHRNF

2 minute read

Cybin’s Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder

By Lara Goldstein

Today, 4:03 PM

Psychedelic biopharma company Cybin Inc. (NEO: CYBN) has received FDA Investigational New Drug Application (IND) approval for a Phase 1/2a clinical trial evaluating its proprietary CYB003 for treating major depressive disorder (MDD).

CYBN

2 minute read

Biotech Company Pioneers Trademark Of MDMA Value Chain: Check Out The 2 Formats Available

By Lara Goldstein

Today, 4:03 PM

Pharmala Biotech Holdings Inc. (CSE: MDMA), a company focused on research, development and manufacturing of MDMA and similar class molecules, has registered a trademark for its clinical-grade, Good Manufacturing Practice MDMA product, to be available as “Laneo MDMA.”

CSE:MDMA

2 minute read

DMT Therapy Developer Small Pharma Posts Financial Results, Reaffirms Potential Of Short-Acting Psychedelics

By Lara Goldstein

Today, 4:03 PM

Biotech company Small Pharma Inc. (OTCQB: DMTTF), producer of short-acting psychedelic-assisted therapies for diverse mental health conditions, announced its financial results earlier this month for the fiscal year ended Feb. 28, 2022.

DMTTF

2 minute read

Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014

By Lara Goldstein

Today, 4:03 PM

Mindset Pharma Inc.

MSSTF

2 minute read

Cybin Closes Fiscal Year 2022, Reports Financial Results And Major Achievements

By Lara Goldstein

Today, 4:03 PM

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), a biopharma company focused on progressing “psychedelics to therapeutics” through proprietary drug discovery platforms announced its financial and business results ended March 31, 2022.

CYBN

2 minute read

Numinus Submits New Patent Application To UN Agency For Psilocybe & Novel Fungi Species

By Lara Goldstein

Today, 4:03 PM

Numinus Wellness Inc.

NUMIF

2 minute read

More Acres Of Farmland In Canada For Red Light Holland’s Mushroom Production Plan

By Lara Goldstein

Today, 4:03 PM

The Ontario-based Red Light Holland Corp. (OTC Pink: TRUFF), a company engaged in the production, growth & sale of premium psychedelic mushrooms to the Netherlands, has acquired 100 acres of farmland in Cavan-Monaghan, Peterborough, Ontario.

TRUFF